COVID-19 Vaccine Confidence Among Pregnant Women and Mothers

Completed

• Conditions: Pregnancy Related; Mothers

• Registration Number: NCT04694664
• Lead Sponsor: Pregistry

Brief Summary

The purpose of this study is to assess the level of vaccine confidence and influencers among pregnant women and mothers of school-aged children during the COVID-19 pandemic.

Detailed Description

The WHO has listed "vaccine hesitancy" as one of the top threats to global health.

The COVID-19 pandemic has triggered the need to vaccinate worldwide as soon as a safe and efficacious vaccine becomes available. However preliminary data show that, on average, only 50% to 66% of US adults would be willing to receive COVID-19 vaccination when it becomes available, a percentage lower than what is required for herd immunity to control the pandemic. Furthermore, there is a pressing need to vaccinate children to reopen schools and keeping them safe, as well as to immunize pregnant women through vaccination programs since they constitute a vulnerable population. Vaccine confidence among pregnant women and mothers of school-aged children during the period of COVID-19 pandemic is unknown, leading to an important gap of knowledge that may hinder the upcoming global COVID-19 vaccination scale-up effort. It is therefore of critical importance to assess the level of vaccine confidence and influencers among pregnant women and mothers of school-aged children during the COVID-19 pandemic.

The international nature of the proposed survey will allow the evaluation of vaccine confidence and its influencers among pregnant women and mothers of school-aged children on a global level. Therefore, social and geographic characteristics from different countries and cultures will be available for comparison. The resulting knowledge will be relevant to a large percentage of the world's population. Any country in the world can participate.

Study Timeline

• Study Start: 2020-10-01
• Study First Submitted: 2020-11-01
• Primary Completion: 2020-12-01
• Study Completion: 2020-12-01
• Status Verified: 2021-01
• Study First Submitted QC: 2021-01-01
• Last Update Submitted: 2021-01-01
• Study First Posted: 2021-01-05
• Last Update Posted: 2021-01-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 18000

Inclusion Criteria

• Pregnant women or women who have at least one child younger than 18 years of age. Able to give electronic informed consent

Exclusion Criteria

• <18 years of age

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of acceptance of a COVID-19 vaccine	up to 2 months	This outcome will evaluate the hesitancy or acceptance to a COVID-19 vaccine

Trial Locations

Locations (1)

Pregistry; 🇺🇸 Los Angeles, California, United States